Skip to main content
SpringerLink
Log in

Radical cystectomy versus alternative treatments for muscle-confined bladder cancer

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Of the 100 patients with muscle-confined transitional cell cancer of thebladder and ASA score ≤3, 59 underwent radical cystectomy (RC) and41 received non-cystectomy alternative treatments (AT). Median follow-upwas 30.8 and 30.5 months in RC and in AT groups, respectively. Disease-freeand overall survivals were significantly longer in RC group than AT group.Salvage cystectomy was required in approximately 25% of the patients whoreceived AT. AT was associated with higher rate of cancer-related morbidityand cancer progression than RC. Every patient with invasive bladdercancer should be given a chance for cystectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gohenim MA, El-Mekresh MM, El-Baz A, El-Attar IA, Ashamallah A. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol 1997; 158: 393.

    Google Scholar 

  2. Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Arbitani W, Garbeglio A. Results of contemporary radical cystectomy for invasive bladder cancer: A clinichopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991; 145: 45.

    Google Scholar 

  3. Figueroa AJ, Stein JP, Dickinson M, Skinner EC, Thangathurai D, Mikhail MS, Boyd SD, Lieskovsky G, Skinner DG. Radical cystectomy for elderly patients with bladder carcinoma: a updated experience with 404 patients. Cancer1998; 83: 141.

    Google Scholar 

  4. Leibovitch I, Avigad I, Ben-Chaim J, Nativ O, Goldwasser B. Is it justified to avoid radical cystoprostatectomy in elderly patients with transitional cell carcinoma of the bladder? Cancer 1993; 71: 3098.

    Google Scholar 

  5. Holmang S, Hedelin H, Anderström C, Johansson SL. Longterm follow-up of all patients with muscle invasive (stages T2, T3 and T4) bladder carcinoma in a geographical region. J Urol1997; 158: 389.

    Google Scholar 

  6. Fossa SD, Woehre H, Aass N, Jacobsen AB, Olsen DR, Ous S. Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer: A retrospective analysis of 317 patients. Cancer 1993; 72: 3036.

    Google Scholar 

  7. Angulo JC, Sanchez-Chapado M, Lopez JI, Flores N. Primary cisplatin, methotrexate and vinblastin aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors. J Urol 1996; 155: 1897.

    Google Scholar 

  8. Dandekar NP, Tongaonkar FIB, Dalal AV, Kulkarni SN. Partial cystectomy for invasive bladder cancer. J Surg Oncol 1995; 60: 24.

    Google Scholar 

  9. Solsona E, Iborra I, Ricos JV, Monros JL, Dumont R. Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: Prospective study. J Urol 1992; 147:1513.

    Google Scholar 

  10. Housset M, Maulard C, Chretien Y, Dufour B, Delanian S, Huart J, Colardelle F, Brunel P, Bailet F. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study. J Clin Oncol 1993; 11: 2150.

    Google Scholar 

  11. Shipley WU, Zietman AL, Kaufman DS, Althausen AF, Heney NM. Invasive bladder cancer: Treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservation. Int J Radiation Oncology biol Phys 1997; 39: 937.

    Google Scholar 

  12. Herr HW, Shcer HI. Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. J Clin Oncol 1994; 12: 975.

    Google Scholar 

  13. Harmer MH, editor. UICC. TNM classification of malignant tumours, 3rd edn. Geneva: International Union Against Cancer, 1978.

    Google Scholar 

  14. Harker W, Meyers FJ, Freiha FS, Palmer JM, Shortliffe LD, Hannigan JF, McWhirter KM, Torti FM. Cisplatin, methotrexate and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional carcinoma of the urinary tract: A Northern California Oncology Group study. J Clin Oncol 1985; 3: 1463.

    Google Scholar 

  15. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.

    Google Scholar 

  16. Cox DR. Regression models and life tables. J Roy Stat Soc Ser B 1972; 34: 187.

    Google Scholar 

  17. Prout GR, Griffin PP, Shipley WV. Bladder carcinoma as a systemic disease. Cancer 1979; 43: 2532.

    Google Scholar 

  18. Montie JE, Straffon RA, Stewart BH. Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol 1984; 131: 477.

    Google Scholar 

  19. Pollack A, Zagars GK, Cole CJ, Dinney CPN, Swanson DA, Grossman HB. The relationship of local control to distant metastasis in muscle invasive bladder cancer. J Urol 1995; 154: 2059.

    Google Scholar 

  20. Gospodarowicz MK, Warde P. The role of radiation therapy in the management of transitional cell carcinoma of the bladder. Hematol Oncol Clin N Amer 1992; 6: 147.

    Google Scholar 

  21. Scattony V, Pozzo L, Nava L, Broglia L, Galli L, Torelli T, Campo B, Maffezzini M, Rigatti P. Five-year results of neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy plus radical cystectomy in locally advanced bladder cancer. Eur Urol 1995; 28: 102.

    Google Scholar 

  22. Dimopoulos MA, Moulopoulos La. Role of adjuvant chemotherapy in the treatment of invasive carcinoma of the urinary bladder. J Clin Oncol 1998; 16: 1601.

    Google Scholar 

  23. Caffo O, Fellin G, Graffer U, Luciani L. Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma: A survey by a self-administered questionnaire. Cancer 1996; 78: 1089.

    Google Scholar 

  24. Hautmann RE, Paiss T. Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy? J Urol 1998; 159: 1845.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Urology, Hacettepe University, Ankara, Turkey

    Ali Tekin, Fazil Tuncay Aki & Haluk Ozen

Authors
  1. Ali Tekin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fazil Tuncay Aki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haluk Ozen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tekin, A., Aki, F.T. & Ozen, H. Radical cystectomy versus alternative treatments for muscle-confined bladder cancer. Int Urol Nephrol 33, 357–362 (2001). https://doi.org/10.1023/A:1015261628978

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015261628978

Keywords

Search

Navigation